DrugPatentWatch Database Preview
Somerset Company Profile
What is the competitive landscape for SOMERSET, and what generic alternatives to SOMERSET drugs are available?
SOMERSET has seventeen approved drugs.
There are three US patents protecting SOMERSET drugs.
There are three patent family members on SOMERSET drugs in two countries and fourteen supplementary protection certificates in nine countries.
Summary for Somerset
| International Patents: | 3 |
| US Patents: | 3 |
| Tradenames: | 15 |
| Ingredients: | 13 |
| NDAs: | 17 |
| Patent Litigation for Somerset: | See patent lawsuits for Somerset |
Drugs and US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-005 | Jun 15, 2018 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | RX | Yes | Yes | 7,150,881 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Somerset | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 019334-001 | Jun 5, 1989 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,150,881 | ➤ Sign Up |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,638,140 | ➤ Sign Up |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | 7,638,140 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Somerset
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,846,093 | Adhesive mixture for transdermal delivery of highly plasticizing drugs | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Somerset Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | H1160475 | ➤ Sign Up |
| European Patent Office | 0887075 | ➤ Sign Up |
| European Patent Office | 1561461 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Somerset Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0042 | Belgium | ➤ Sign Up | PRODUCT NAME: CHLORHYDRATE DE ROPIVACAINE MONOHYDRATE; NAT. REGISTRATION NO/DATE: 212 IS 216 F 12 19960806; FIRST REGISTRATION: SE 12319 19950915 |
| /2015 | Austria | ➤ Sign Up | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| 00722 | Netherlands | ➤ Sign Up | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
